Asuragen Scientific Publications

Asuragen has researched and published extensively in genetics, oncology, molecular diagnostics, and technology advancements for over 15 years. These publications, posters, and white papers cover various disease areas and their related genes including fragile X (FMR1), spinal muscular atrophy (SMN1/SMN2), cystic fibrosis (CFTR), and chronic myeloid leukemia (BCR-ABL1). They show the power of detecting and interpreting molecular alterations using AmplideX and QuantideX technologies as well as the value of Molecular Quality Controls and companion diagnostics collaborations to deliver new insights and advance precision medicine. Simply search by term, filter by category, or use both to find your area of interest.

We’re driven to provide people with better answers, so we ensure our products are supported by reliable data and backed by rigorous science. Dive into these publications to learn more.

Rapid, Equitable Molecular Confirmation of Pathogenic Variants in the CFTR Gene for Cystic Fibrosis Testing with Dried Blood Spots
Kevin Kelnar , Sarah Edelmon, Steven Partin, Elliot Hallmark, Connor Parker, John Hedges, John N. Milligan
Accessible Fragment Analysis Instrumentation Allows Resolution of Challenging Genotypes Associated with Pathogenic Repeats, Structural Variants, SNVs and INDELS
Sarah Edelmon, Steven Partin, Adrian Lara, Jackie Peda, John Hedges, John N Milligan
An Exosome-based ESR1 Monitoring RT-qPCR Technology That Rapidly and Accurately Detects Circulating Tumor Acquired Resistance Variants at ≤ 0.1% Frequency in Liquid Biopsy Samples
Sarah Statt1, Julie R. Thibert, Liangjing Chen, J. Aquiles Sanchez, Kurt Franzen, Megan Yociss, Elliot Hallmark, Melissa Church, Stela Filipovic-Sadic, Gary J. Latham and Johan Skog
An Amplification-based, Nanopore Carrier Screening Panel Resolves ClinicallyRelevant Variants in CFTR, SMN1/2, HBA1/2, HBB, and FMR1 in a Unified Workflow
Bradley Hall, Bryan Killinger, Christopher J. Fraher, Bradley Martin, Monica Roberts, Jonathan Turner, Pranesh Rao, Ryan Routsong, Gary J. Latham
Long-Range PCR and Nanopore Sequencing Method Resolves F8, GBA, CYP21A2, SMN1, and TNXB Variants Using a Single Streamlined Workflow
Cody Edwards, Bryan Killinger, Theodore Markulin, Monica Roberts, Ryan Routsong, Jon Kemppainen, Adrian Lara, Sarah Statt, Bradley Martin, Gary Latham, and Bradley Hall
A Comprehensive PCR/Nanopore Based Panel for CFTR Population Carrier Screening that Resolves Multiple Classes of Clinically-Relevant Variants
Monica P. Roberts, Ryan Routsong, Pranesh Rao, Christopher J. Fraher, Bradley C. Hall, Gary J. Latham, Brian C. Haynes, and Bryan J. Killinger
High-resolution Analysis of Pathogenic Trinucleotide and Hexanucleotide Repeats, Copy Number Changes, SNVs and INDELs Using Flexible, Easy-to-use Fragment Sizing Instrumentation
Adrian Lara, Connor Parker, Steven Partin, John Hedges, John Milligan Categories: poster, genetics
ASHG Platform Presentation: A whole exon targeted PCR/Nanopore sequencing assay that reveals SNVs, indels and CNVs across SMN1 and SMN2 with implications for SMA carriers and disease severity
Pranesh Rao, Jon Kemppainen, Cody Edwards, Walairat Laosinchai-Wolf, Nisha Vishag, Dr. Bradley Hall, Dr. Gary Latham, Ryan Routsong, Dr. Bradley Martin, Dr. Bryan Killinger, Christopher J. Fraher
Molecular Controls for SARS-CoV-2 and Influenza A/B Testing in Microchip-based RT-PCR Test Systems
Sikander Gill, Rajwant Gill, Natallia Varankovich, Irina Gelimson, Chandanee Dancey, Kelly Jackson, Steven Bailey, Emoni Robinson, Frank Hui, Andre Brown, Richard Elliott, Maxim Slyadnev, and Deepa Eveleigh
Reverse Transcription Cycling Achieves Greater Than 100% cDNA Conversion With Implications For Ultra-High Sensitivity of Clinically-Actionable, Oncogenic RNA Mutations
Melissa Church, Rebecca Rinehart, Shobha Gokul, Liangjing Chen, Stela Filipovic-Sadic, and Gary J Latham
Search
Filter

Publication Categories

Publication Types

Clear All Filters
Back To
Top